Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera: Preliminary Results from the Three-Year Analysis of the Daliah Trial - a Randomized Controlled Phase III Clinical Trial

Blood - Tập 132 - Trang 580 - 2018
Trine Alma Knudsen1, Dennis Lund Hansen2, Lukas Frans Ocias3, Ole Weis Bjerrum4, Mette Brabrand2, Daniel El Fassi5, Mikael Frederiksen6, Lasse Kjær1, Thomas Kielsgaard Kristensen7, Torben A Kruse8, Torben Mourits-Andersen9, Peter Møller1, Ulrik Malthe Overgaard4, Marianne Tang Severinsen10, Vibe Skov1, Jesper Stentoft11, Jørn Starklint12, Karin de Stricker13, Mads Thomassen8, Thomas Stauffer Larsen2
1Department of Hematology, Zealand University Hospital, Roskilde, Denmark
2Department of Hematology, Odense University Hospital, Odense, Denmark
3Department of Hematology, Odense University Hostpial, Odense, Denmark
4Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
5Department of Hematology, Herlev University Hospital, Copenhagen, Denmark
6Department of Hematology, Hospital of Southern Jutland, Haderslev, Denmark
7Department of Pathology, Odense University Hospital, Odense, Denmark
8Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark
9Department of Hematology, Hospital of South West Jutland, Esbjerg, Denmark
10Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
11Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
12Department of Hematology, Hospital of West Jutland, Holstebro, Denmark
13Department of Clinical Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Thông tin
Thông tin xuất bản

Blood

Tập 132

580

Thông tin tác giả